BRIEF-Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right

Reuters
21 Jul
BRIEF-Iteos <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right

July 21 (Reuters) - Iteos Therapeutics Inc ITOS.O:

  • ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

  • ITEOS THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $10.047 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

  • ITEOS THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVES ACQUISITION BY CONCENTRA

  • ITEOS THERAPEUTICS INC - CONCENTRA TO COMMENCE TENDER OFFER BY AUGUST 1, 2025

Source text: ID:nGNX3FrWhC

Further company coverage: ITOS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10